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Mammals exhibit poor recovery after spinal cord injury (SCI), whereas non-mammalian
vertebrates exhibit significant spontaneous recovery after SCI. The mechanisms
underlying this difference have not been fully elucidated; therefore, the purpose of this
study was to investigate these mechanisms. Using comparative transcriptome analysis,
we demonstrated that genes related to cell cycle were significantly enriched in the
genes specifically dysregulated in zebrafish SCI. Most of the cell cycle-related genes
dysregulated in zebrafish SCI were down-regulated, possibly through activation of e2f4.
Using a larval zebrafish model of SCI, we demonstrated that the recovery of locomotive
function and neuronal regeneration after SCI were significantly inhibited in zebrafish
treated with an E2F4 inhibitor. These results suggest that activation of e2f4 after SCI may
be responsible, at least in part, for the significant recovery in zebrafish. This provides novel
insight into the lack of recovery after SCI in mammals and informs potential therapeutic
strategies.
Keywords: spinal cord injury, systems pharmacology, comparative transcriptome analysis, zebrafish, E2F4,
DREAM complex
INTRODUCTION
Spinal cord injury (SCI) in mammals typically results in permanent neurological deficits, whereas
regenerative organisms, such as amphibians and fish, are capable of regeneration after SCI
(reviewed in Lee-Liu et al., 2013; Vajn et al., 2013; Silver et al., 2015). Certain key differences
between regenerative and non-regenerative organisms have been identified. For example, in
regenerative organisms, astroglial cells form a bridge, and aid axonal elongation after injury. In
contrast, after SCI in mammals astrocytes form a glial scar and secrete extracellular matrix (ECM)
components such as chondroitin sulfate and proteoglycans. These extrinsic mechanisms can cause
a relative lack of growth-promoting molecules and/or a surplus of growth-inhibitory molecules,
Abbreviations: SCI, Spinal cord injury; ECM, extracellular matrix; DEGs, differentially expressed genes; TFs, transcription
factors; DREAM complex, TFDP1, RBL2, E2F4, and the MuvB core complex; dpi, days-post-injury; dpf, days-post-
fertilization.
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which can result in the inhibition of axonal regeneration in
mammalian SCI. It has also been demonstrated that the intrinsic
propensity for axonal growth is different between regenerative
and non-regenerative organisms. For example, the expression of
miR-133b was increased at 1 and 7 days after SCI in zebrafish
and knockdown of miR-133b significantly attenuated axonal
regeneration (Yu et al., 2011). In contrast, the expression of miR-
133b was transiently increased at 4 h after SCI and dramatically
decreased at 1 day after SCI in rat (Liu et al., 2009). There are
several targets of miR-133b that are involved in regeneration
after SCI (Vajn et al., 2013). The balance between extrinsic and
intrinsic molecular events may determine the overall axonal
regeneration response. A comprehensive understanding of the
mechanisms underlying the difference between non-regenerative
and regenerative organisms is therefore still required.
Transcriptome analysis using microarrays and high-
throughput sequencing have provided new insights into the
pathogenesis of various disorders, including SCI in mouse (Chen
et al., 2013; Wu et al., 2013), rat (Di Giovanni et al., 2003;
Chamankhah et al., 2013; Chen et al., 2015), and zebrafish (Ma
et al., 2012; Hui et al., 2014). These studies included time-series
expression analysis; the clustering of differentially expressed
genes (DEGs) based on their temporal expression patterns. This
approach has revealed molecular events occurring in the acute,
subacute, and chronic stage of SCI. Recently, genome-wide
expression profiling was performed to compare the response
to SCI in Xenopus laevis at regenerative and non-regenerative
stages (Lee-Liu et al., 2014). The analysis revealed that very
different sets of transcripts are produced in the regenerative and
non-regenerative stages after SCI.
These findings suggest that there might be differences in
the DEGs between regenerative and non-regenerative organisms
after SCI and that there might be transcription factors (TFs)
regulating the DEGs that might be selectively activated or
inhibited in either regenerative or non-regenerative organisms.
To identify these TFs, we applied systems biology approaches to
public transcriptome data for SCI in zebrafish (Hui et al., 2014),
mouse (Wu et al., 2013), and rat (Chamankhah et al., 2013).
We were able to identify several TFs selectively functioning in
zebrafish SCI ormouse/rat SCI.Wewere also able to demonstrate
that e2f4, a member of the DREAM complex (TFDP1, RBL2,
E2F4, andMuvB core complex) and a master coordinator of cell
cycle dependent gene transcription (Sadasivam and DeCaprio,
2013), was selectively activated in zebrafish SCI and promoted
neuronal regeneration and functional recovery.
MATERIALS AND METHODS
Ethics Statement
This study was carried out in strict accordance with Japanese law
[The Humane Treatment and Management of Animals (2014)1,
Standards Relating to the Care and Management of Laboratory
Animals and Relief of Pain (2013)2 and the Guidelines for Proper
1Ministry of the Environment Japan, 2014, The Law for the Humane Treatment
andManagement of Animals, Law No. 105, October 1, 1973, revised May 30, 2014.
2Ministry of the Environment Japan, Standards Relating to the Care and
Management of Laboratory Animals and Relief of Pain, 2013, Notice No. 88, April
28, 2006, revised August 30, 2013.
Conduct of Animal Experiments (Science Council of Japan,
2006)3]. All surgery was performed under 2-phenoxyethanol
anesthesia, and all efforts were made to minimize suffering.
Compounds
HLM006474 was obtained from Tocris (Bristol, UK). A stock
solution of HLM006474 was prepared by dissolving in dimethyl
sulfoxide (Nacalai Tesque, Kyoto, Japan). 2-phenoxyethanol was
obtained fromWako Chemical (Osaka, Japan).
Comparative Transcriptome Analysis
To compare DEGs among mouse, rat, and zebrafish SCI, we used
three transcriptome data sets deposited in the Gene Expression
Omnibus (GEO; Barrett et al., 2009). In the mouse SCI model
(Wu et al., 2013), T9 was injured by contusion with an impactor.
In the rat SCI model (Chamankhah et al., 2013), T7 was injured
by compression with a clip. In the zebrafish SCI model (Hui
et al., 2014), the 15/16th vertebrae was injured by crushing
dorso-ventrally with forceps. In these models, the spinal cord
containing the epicenter of the injured tissues was extracted for
the transcriptome analysis. The raw transcriptome analysis data
of mouse SCI (GSE47681) (Wu et al., 2013), rat SCI (GSE45006)
(Chamankhah et al., 2013), and zebrafish SCI (GSE39295) (Hui
et al., 2014) were downloaded from GEO (Barrett et al., 2009).
The raw data were normalized using “affy” (Gautier et al., 2004)
for GSE47681 and GSE45006 or “limma” (Ritchie et al., 2015)
for GSE39295 in Bioconductor (Gentleman et al., 2004). Probes
with reliable signals were selected and subjected to “RankProd”
(Hong et al., 2006) to identify DEGs in SCI compared to sham in
each model using a false discovery rate of 20% as the threshold.
The gene symbols of DEGs in each model were converted to
those of human orthologous genes using Life Science Knowledge
Bank (World Fusion, Tokyo, Japan). SwissProt IDs of the human
orthologous genes were added using BioMart (Smedley et al.,
2015). The list of DEGs is shown in Tables S1, S2 for 1 dpi and 3
dpi, respectively. Venn diagrams of the number of DEGs in these
models were drawn using “PINA4MS” (Cowley et al., 2012) in
Cytoscape (Shannon et al., 2003).
Identification of Enriched Gene Ontologies
in DEGs
To identify enriched gene ontologies in a given gene list, we
used DAVID (Huang Da et al., 2009) with medium classification
stringency. The clustering algorithm is based on the hypothesis
that similar annotations should have similar gene members.
The Group Enrichment Score is the geometric mean (in -log
scale) of a member’s p-values in a corresponding annotation
cluster. DEGs specific for zebrafish SCI (Tables S1-8, S2-8),
DEGs specific for mouse/rat SCI (Tables S1-9, S2-9), DEGs
specific for zebrafish SCI potentially regulated by at least two
TFs among e2f4, tfdp1 and foxm1 (Tables S5-1,S5-2), and DEGs
specific for mouse/rat SCI potentially regulated by Nfic and
Tead4 (Table S5-3,S5-4) were subjected to DAVID. The clusters
of enriched gene ontologies for these DEGs are shown in
Tables S3, S6.
3Science Council of Japan, 2006, Guidelines for Proper Conduct of Animal
Experiments, www.scj.go.jp/ja/info/kohyo/pdf/kohyo-20-k16-2e.pdf
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Identification of Transcription Factors
Regulating DEGs Using iRegulon
iRegulon exploits the fact that genes that are co-regulated by
the same TF commonly share binding sites for the TF and uses
gene sets derived from ENCODE ChIP-seq data (Gerstein et al.,
2012; Janky et al., 2014). We used iRegulon as an application
in Cytoscape (Shannon et al., 2003; Nishimura et al., 2015c;
Sasagawa et al., 2016). The lists of DEGs specific for zebrafish SCI
(Tables S1-8, S2-8) or mouse/rat SCI (Tables S1-9, S2-9) were
subjected to iRegulon using the default settings. The predicted
transcriptional regulators with normalized enrichment scores
(NES) >3.5 are shown in Table S4.
Zebrafish Strains
We used an albino zebrafish line (Kelsh et al., 1996) obtained
from the Max Planck Institute for Developmental Biology
(Tübingen, Germany; Watanabe et al., 2012) for locomotive
behavior analysis. We also developed Tg(eno2: Cerulean)
zebrafish. The coding region of Cerulean was amplified by PCR
using pCS2+8NCerulean (Addgene, Cambridge, MA, USA) as
the template. The PCR product was cloned into Tol2 vector
using the In-fusion HD cloning kit (Takara Bio, Shiga, Japan).
Briefly, a fragment (from bp 3017 to 1088) of pT2AL200R150G
(Kawakami, 2007) was amplified by inverse PCR and fused
with the coding region of Cerulean to make a circular plasmid
(pT2-cerulean). The promoter of zebrafish eno2 (from –3783
to 3723 bp) (Bai et al., 2007) was synthesized by Invitrogen
(Carlsbad, CA, USA) and cloned into pT2-cerulean using
the In-fusion HD cloning kit (Takara Bio) to make pT2-
eno2-cerulean. pT2-eno2-cerulean and transposase mRNA were
injected into zebrafish embryos at the 1–8 cell stage. Larval
zebrafish expressing Cerulean or mCherry in the spinal cord
were selected and maintained. Mature F0 zebrafish were mated
with albino zebrafish. The F1 zebrafish expressing Cerulean were
selected and used for in vivo imaging.
Zebrafish were bred and maintained according to previously
described methods (Westerfield, 2007; Nishimura et al., 2016).
Briefly, zebrafish were raised at 28.5 ± 0.5◦C with a 14 h/10
h light/dark cycle. Embryos were obtained via natural mating
and cultured in 0.3× Danieau’s solution [19.3 mM NaCl, 0.23
mM KCl, 0.13 mM MgSO4, 0.2 mM Ca(NO3)2, 1.7 mM
HEPES, pH 7.2] until 8 dpf for behavioral and in vivo imaging
analysis. Zebrafish from 5 dpf were maintained on a diet of live
Paramecium.
Microdissection of the Zebrafish Spinal
Cord
Zebrafish were anesthetized with 500 ppm 2-phenoxyethanol
in 0.3× Danieau’s solution. The probe (EMB-13Y, Nepa Gene,
Chiba, Japan), which was connected to a Gastromaster (GST-1,
Nepa Gene) through an adaptor (EMB-C125G, Nepa Gene), was
placed on the dorsal skin of a zebrafish above the caudal end of
the swim bladder. Then, the foot switch was activated using the
“yellow” setting of the Gastromaster until complete transection of
the spinal cord was made (Movie S1). After surgery, the zebrafish
were transferred to a dish containing 0.3× Danieau’s solution
without 2-phenoxyethanol. After about an hour, zebrafish were
placed individually into wells of a round 48-well-plate (10 mm
diameter, containing 500µL of 0.3×Danieau’s solution). The 48-
well-plate was placed in an incubator at 28.5◦C until the behavior
analysis was performed.
Assessment of Locomotion Behavior in
Zebrafish after SCI
An overview of the behavior analysis is shown in Figure 3. All
behavioral tests were performed during the same time frame
(from 2 to 3 pm at 0, 1, 2, and 3 dpi). A 48-well-plate was placed in
a DanioVision observation chamber (Noldus, Wageningen, The
Netherlands), which was blocked from daylight and illuminated
from below with white light (255 lx) at the time indicated in
Figure 4A. The locomotive behavior of zebrafish in each well was
monitored by the DanioVision system with a resolution of 1024
× 768 pixels at 25 frames per seconds (fps). After assessment of
locomotive behavior at 0 dpi, 500 µL of 0.3× Danieau’s solution
with or without 5 µMHLM006474 was added to each well of the
48-well-plate and the plate was then placed in an incubator at
28.5◦C with constant light (255 lx) from 7 a.m. to 9 p.m. until the
behavior analysis was performed the next day. The medium with
and without 5 µM HLM006474 was changed after the behavior
analysis at 0 dpi. Two independent experiments were performed.
The recorded video images were analyzed using EthoVision
XT11 (Noldus) to measure the locomotive behavior of zebrafish
in each well. Mobility was calculated by taking every pixel
identified as the subject and comparing it between the current
image and the previous one (Nishimura et al., 2015b). If all
the pixels were the same, there was zero mobility. If all the
pixels were different, there was 100% mobility. In this study,
we defined 5–35, 35–65, and 65–95% as low, medium, and
high mobility. The distance moved by each fish in the dark
and light periods was calculated for the time showing medium
mobility.
In vivo Imaging of Zebrafish Neurons and
Astrocytes at the Lesion Site after SCI
Zebrafish larvae at 3 dpi with or without HLM006474 treatment
were anesthetized with 2-phenoxyethanol (500 ppm in 0.3×
Danieau’s solution), then transferred onto glass slides. A few
drops of 3% low-melting agarose solution were placed over the
larvae and the larvae were immediately oriented sideways, dorsal-
side-up. The fluorescent signals in the embedded larvae were
observed using an epifluorescent microscope (SMZ25, Nikon,
Tokyo, Japan) using CFP filters to detect Cerulean fluorescence.
Quantitative assessment of the in vivo fluorescence imaging was
performed using Volocity (Perkin Elmer, Cambridge, MA, USA).
Briefly, we placed the region of interest (ROI), a circle 191 µm in
diameter, around the SCI lesion (Figure 5) in the 256-gray-scale
(0–255) image. The area of Cerulean fluorescence in the ROI that
contained pixels over the intensity threshold (30) was calculated
and was used as the fluorescence signal of neurons.
Statistical Analysis
Statistical analysis was performed using Prism 6 (Graphpad, La
Jolla, CA, USA). For the assessment of locomotive behavior, two
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factor ANOVA followed by Sidak’s multiple comparison test was
performed. For the assessment of neuronal regeneration, Welch’s
t-test was performed. Data are shown as the mean± SEM.
RESULTS
Comparative Transcriptome Analysis
Revealed Specific DEGs in Zebrafish SCI
and Mouse/Rat SCI
To identify DEGs that are specific for zebrafish SCI and
mouse/rat SCI, we downloaded transcriptome data of mouse SCI
(GSE47681) (Wu et al., 2013), rat SCI (GSE45006) (Chamankhah
et al., 2013), and zebrafish SCI (GSE39295) (Hui et al., 2014) from
the GEO (Barrett et al., 2009). Using these data, we identified
DEGs in each SCI model using a false discovery rate of 20% as
the threshold. The identified DEGs and their overlap between the
three SCImodels are shown inTables S1, S2 for 1 day-post-injury
(dpi) and 3 dpi, respectively. Venn diagrams of the numbers of
DEGs in these SCI models are shown in Figure 1.
At 1 dpi, 36 DEGs were common among mouse, rat and
zebrafish. For 19 of these 36 DEGs, the change in expression was
the same in mouse, rat, and zebrafish (Table S1-4), whereas for
17 genes the change in expression was opposite between zebrafish
and mouse/rat (Table S1-5). A total of 186 DEGs were identified
in zebrafish SCI that were not identified in mouse and/or rat
SCI (Table S1-6). Among the 573 DEGs that overlapped between
mouse and rat SCI, the change in expression was the same for
553 genes (Table S1-7). In summary, we identified 203 DEGs that
were specific for zebrafish SCI (17 DEGs with opposite changes in
expression between zebrafish and mouse/rat SCI plus 186 DEGs
unique to zebrafish SCI) (Table S1-8) and 570 DEGs that were
specific for mouse/rat SCI (17 DEGs with opposite changes in
expression between mouse/rat and zebrafish SCI plus 553 DEGs
unique to mouse/rat SCI) (Table S1-9).
FIGURE 1 | Venn diagrams of differentially expressed genes in mouse,
rat and zebrafish SCI. Transcriptome data of SCI in mouse (GSE47681), rat
(GSE45006), and zebrafish (GSE39295) were downloaded from a public
database (GEO). The DEGs between SCI and control groups in each model at
1 or 3 dpi were identified using a false discovery rate of 20% as the threshold.
The numbers of DEGs in each group and the overlap between groups are
shown in the Venn diagrams.
At 3 dpi, 23 DEGs were common among mouse, rat and
zebrafish. Of the 23 DEGs, eight had the same change in
expression amongmouse, rat and zebrafish (Table S2-4), whereas
the expression change of 12 genes was opposite between zebrafish
and mouse/rat (Table S2-5). The expression changes of three
genes were opposite between mouse and rat (data not shown). In
zebrafish SCI, 337 DEGs were identified that were not identified
in mouse and/or rat SCI (Table S2-6). Among the 481 DEGs
that overlapped between mouse and rat SCI, the changes in
expression of 419 genes were the same between mouse and rat
(Table S2-7). In summary, we identified 349 DEGs specific for
zebrafish SCI (12 DEGs with opposite changes in expression
between zebrafish and mouse/rat SCI plus 337 DEGs unique to
zebrafish SCI) (Table S2-8) and 431 DEGs specific for mouse/rat
SCI (12 DEGs with opposite changes in expression between
mouse/rat and zebrafish SCI plus 419 DEGs unique to mouse/rat
SCI) (Table S2-9).
Genes Related to Cell Cycle Were Enriched
in DEGs Specific for Zebrafish SCI
To reveal the functions of DEGs specific for zebrafish or
mouse/rat SCI, we performed gene ontology analysis using
DAVID (Huang Da et al., 2009). The analysis revealed that
genes related to cell cycle, including mitosis and cyclin, were
significantly enriched in DEGs specific for zebrafish SCI at 1 dpi
(Table S3-1) and 3 dpi (Table S3-2). Genes related to cell cycle
were not enriched in DEGs specific for mouse/rat SCI. Inhibition
of cell cycle can stimulate recovery after SCI in mammals (Tian
et al., 2007; Wu et al., 2011, 2012). Cell cycle activation after
SCI appears to contribute not only to apoptotic cell death of
post-mitotic neuronal cells, but also to post-traumatic gliosis and
microglial activation (Wu et al., 2011). Therefore, the enrichment
of genes related to cell cycle in zebrafish SCI-specific DEGs
may be the primary mechanism for neuronal regeneration and
functional recovery after SCI in zebrafish, but not in mouse
and rat.
Genes Related to Cell Adhesion Were
Enriched in DEGs Specific for Mouse/Rat
SCI
We also revealed that genes related to cell adhesion were
significantly enriched in DEGs specific for mouse/rat SCI at 1
dpi (Table S3-3) and 3 dpi (Table S3-4). Genes related to cell
adhesion were not enriched in DEGs specific for zebrafish SCI.
ECM components, such as chondroitin sulfate, proteoglycans
and tanascins are known to be up-regulated after injury and to
stimulate cell adhesion and contribute to the growth-inhibitory
effects of the glial scar (Busch and Silver, 2007). These findings
suggest that cell adhesion may be related to the poor recovery
from SCI in mammals.
Identification of TFs Regulating Zebrafish
SCI-Specific DEGs
To identify TFs regulating DEGs specific for zebrafish SCI or
mouse/rat SCI, we used iRegulon, a bioinformatics analysis tool
that has been successfully used to identify TFs for given gene
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lists (Janky et al., 2014; Nishimura et al., 2015c; Sasagawa et al.,
2016). The analysis identified four and seven TFs potentially
regulating DEGs specific for zebrafish SCI at 1 and 3 dpi,
respectively (Table S4-1). e2f4, tfdp1, and foxm1 were common
among the DEGs at 1 and 3 dpi. Figure 2A demonstrates the
genes that were selectively dysregulated in zebrafish SCI, possibly
through e2f4, tfdp1, and foxm1. The genes regulated by at
least two of e2f4, tfdp1, and foxm1 are shown in the inner
circle. Most of the genes in the circle were down-regulated
(Tables S5-1,S5-2).
FIGURE 2 | Identification of e2f4/tfdp1/foxm1 and Nfic/Tead4 as the key TFs that regulate DEGs specific for zebrafish or mouse/rat SCI. (A) DEGs
specific for zebrafish SCI potentially regulated by e2f4, tfdp1 and/or foxm1 at 1 or 3 dpi are shown. (B) DEGs specific for mouse/rat SCI potentially regulated by Nfic
and/or Tead4 at 1 or 3 dpi are shown.
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Identification of TFs Regulating Mouse/Rat
SCI-Specific DEGs
We also identified TFs potentially regulating DEGs specific for
mouse/rat SCI at 1 and 3 dpi (Table S4-2). Two transcriptional
activators Nfic (Pjanic et al., 2011) and Tead4 (Jacquemin et al.,
1996) were common between the DEGs at 1 and 3 dpi. The
DEGs potentially regulated by Nfic and/or Tead4 are shown in
Figure 2B. Most of the DEGs were upregulated in mouse/rat
SCI, suggesting that both Nfic and Tead4 may be activated in
mouse/rat SCI. Genes related to cell adhesion were significantly
enriched in the genes potentially regulated by both Nfic and
Tead4 at 1 but not 3 dpi (Tables S5-3, S6-3 for 1 dpi, Tables S5-4,
S6-4 for 3 dpi). These results suggest that activation of Nfic and
Tead4 may contribute to the regulation of DEGs specific for
mouse/rat DEG, at least at 1 dpi.
The Recovery of Locomotive Behavior
after SCI Was Inhibited in Zebrafish
Treated with E2F4 Inhibitor
We wanted to examine whether inhibition of e2f4 would affect
the recovery of zebrafish locomotive behavior after SCI. In this
study, we developed a novel SCI model using larval zebrafish
(Figure 3). Using a microdissection device, complete transection
of the spinal cord was made above the caudal end of the swim
bladder in zebrafish at 5 days post fertilization (dpf;Movie S1).
To examine the locomotive ability of zebrafish, we utilized
the zebrafish behavior of responding to a change in light/dark
conditions during short periods (MacPhail et al., 2009;
Nishimura et al., 2015a). The experimental conditions are shown
in Figure 4A. The locomotion of zebrafish increases greatly when
the conditions change from light to dark (Movie S2), whereas
the locomotion decreases when the conditions change from
dark to light. Additional cycles of alternating light and dark
reliably produce alternating levels of low and high locomotion,
respectively (MacPhail et al., 2009). The locomotive behavior
of zebrafish with SCI treated with or without HLM006474, an
inhibitor of E2F4 (Ma et al., 2008), is shown in Figure 4B–D.
The recovery of locomotive behavior during the dark periods
was significantly lower in zebrafish treated with HLM006474
(Figure 4C). The locomotive behavior during the base and light
periods were not significantly different between zebrafish with
and without treatment of HLM006474 (Figures 4B,D). The
locomotive behavior of control zebrafish was also not affected
by HLM006475 treatment during the base, dark or light periods
(Figure 4E–G). These results suggest that inhibition of e2f4
attenuates the functional recovery of zebrafish after SCI.
Neuronal Regeneration after SCI Was
Attenuated in Zebrafish Treated with E2f4
Inhibitor
We then examined whether the inhibition of e2f4might attenuate
the neuronal regeneration of spinal cord in zebrafish after SCI.
We performed in vivo imaging of zebrafish selectively expressing
a fluorescent protein, Cerulean, in neurons under the control
of the eno2 promoter (Figure 5A). As shown in Figures 5B,C,
treatment of HLM006474 significantly reduced the regeneration
of neurons at 3 dpi. These results suggest that inhibition of e2f4
attenuates neuronal regeneration after SCI in zebrafish.
DISCUSSION
Regulation of Zebrafish SCI-Specific DEGs
through E2F4, TFDP1, and FOXM1
In this study, we demonstrated that e2f4, tfdp1, and foxm1
possibly regulate zebrafish SCI-specific DEGs. E2F4 and TFDP1
are members of the DREAM complex, the master coordinator
of the cell cycle (Sadasivam and DeCaprio, 2013). The DREAM
complex regulates down-regulation of genes related to mitosis
FIGURE 3 | Larval zebrafish SCI model used in this study. At 5 dpf, the spinal cords of zebrafish were injured using a device for microdissection (Movie S1). At
0, 1, 2, and 3 dpi, the locomotive behavior of zebrafish was analyzed (Figure 4, Movies S2, S3). At 3 dpi, in vivo imaging of the spinal cord was performed
(Figure 5). A representative SCI in zebrafish is indicated by the red arrow.
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FIGURE 4 | Recovery of zebrafish locomotive behavior after SCI was inhibited by treatment with E2F4 inhibitor. (A) Protocol for the assessment of
zebrafish locomotive behavior. Zebrafish were placed in each well of a 48-well-plate. The plate was set in a device to monitor the behavior of zebrafish in real-time. In
the device, the plate was illuminated for 30 min for acclimatization, followed by five sets of dark (3 min) and light (3 min) periods. Zebrafish with SCI (B–D) or without
SCI (E–G) were treated with an E2F4 inhibitor HLM006474 (5 µM) or with vehicle. The distance moved during the base (30 min, B,E), dark periods (15 min, C,F) or
light periods (15 min, D,G) are shown. N = 36 for each group with SCI and eight for each group without SCI. #p < 0.05 compared to SCI without HLM006474.
when cells exit the cell cycle and enter into G0 phase in response
to differentiation signals or absence of growth factors (Sadasivam
and DeCaprio, 2013). When cells leave G0 and enter into the cell
cycle, RBL2 dissociates from E2F4 and theMuvB core resulting in
the release of the DREAM complex from the promoters of genes
related to the cell cycle (Sadasivam and DeCaprio, 2013). When
cells enter into the G2/M stage, the MuvB core proteins associate
with FOXM1, activating the expression of genes related to the
G2/M stage, including CCNA2, CCNB2, NEK2, and PLK1 (Teh
et al., 2010; Bella et al., 2014). The expression of these genes was
down-regulated in zebrafish SCI at 1 and 3 dpi (Tables S1, S2),
suggesting that e2f4 and tfdp1 may be activated and foxm1 may
be inhibited after SCI in zebrafish. Genes related to the cell cycle
were also significantly enriched in the DEGs specific for zebrafish
SCI potentially regulated by at least two of e2f4, tfdp1 and foxm1
at 1 and 3 dpi (Tables S5, S6), suggesting important roles of these
TFs in the regulation of DEGs specific for zebrafish SCI.
Regulation of Mouse/Rat SCI-Specific
DEGs
In this study, we demonstrated that Nfic and Tead4 may
contribute to the regulation of DEGs specific for mouse/rat
DEG. We cannot exclude the possibility, however, that other
important factors may regulate the DEGs specific for mammalian
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FIGURE 5 | Neuronal regeneration after SCI was impaired in zebrafish treated with E2F4 inhibitor. (A) Representative in vivo imaging of Tg(eno2: Cerulean)
zebrafish. (B) Representative in vivo imaging of Tg(eno2: Cerulean) zebrafish with SCI at 3 dpi treated with or without HLM006474. (C) The Cerulean area in the ROI
was quantified and compared between zebrafish with SCI treated with or without HLM006474. N = 24 and 22 for zebrafish without and with HLM006474,
respectively. #p < 0.05 compared to SCI without HLM006474.
SCI. It has been demonstrated that the expression of miR-
133b was increased and decreased after SCI in zebrafish
(Yu et al., 2011) and rat (Liu et al., 2009), respectively.
Connective tissue growth factor (CTGF) is a target of miR-133,
and it is down-regulated by miR-133 (Duisters et al., 2009).
Furthermore, the expression of CTGF in reactive astrocytes was
significantly increased through the down-regulation of miR-
133b (Xin et al., 2013), while CTGF expression by reactive
astrocytes is associated with matrix deposition and glial scar
formation in human cerebral infarction (Schwab et al., 2000).
These findings suggest that down-regulation of miR-133b may
be responsible, at least in part, for DEGs specific to mammalian
SCI. Consistent with this, 19 genes identified as mammalian
SCI-specific DEGs at 3 dpi are also predicted to be targets of
miR-133b (Wong and Wang, 2015). Further studies are required
to elucidate the mechanisms regulating DEGs specific for
mammalian SCI.
Activation of E2F4 is Responsible for
Significant Recovery after SCI in Zebrafish
We demonstrated that the recovery of locomotive function and
neuronal regeneration after SCI were significantly inhibited in
zebrafish treated with HLM00646, an E2F4 inhibitor, suggesting
that activation of e2f4 after SCI may be responsible, at least in
part, for significant recovery in zebrafish. To our knowledge,
E2F4 is the only target of HLM00646; however, we cannot exclude
the possibility that HLM00646 inhibited zebrafish SCI recovery
through targeting molecules other than e2f4. Experiments using
e2f4 knock-down or knock-out zebrafish will confirm the
involvement of e2f4 in the significant recovery from SCI in
zebrafish. The mechanism of how e2f4 is activated after SCI in
zebrafish also remains to be elucidated. It has been demonstrated
that E2F4 does not contain a nuclear localization signal, and
that the nuclear import of E2F4 is stimulated by association with
RBL2 (also called p130) (Moberg et al., 1996). The association
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between E2F4 and RBL2 is stimulated in response to cell cycle
exit (Moberg et al., 1996). It has also been demonstrated that
transcriptional repression activity of the DREAM complex is
regulated by phosphorylation of the MuvB complex (Sadasivam
and DeCaprio, 2013). The MuvB complex is phosphorylated
by DYRK1A (Litovchick et al., 2011). Transient expression
of DYRK1A in neuronal precursors acts as a binary switch,
coupling the end of proliferation and the initiation of neuronal
differentiation (Hammerle et al., 2011). These findings suggest
that the function of e2f4 may be stimulated by association with
rbl2 and activation of dyrk1a after SCI in zebrafish.
The selective activation of e2f4 in zebrafish SCI also suggests
that the function of E2F4 may be inhibited in mammalian SCI. It
has been demonstrated that 4-hydroxynonenal (HNE), a product
of lipid peroxidation, significantly reduced E2F4 protein levels
and increased those of the pRb/E2F1 complex (Barrera et al.,
2004). E2F4 and E2F1 have opposing roles in regulation of
the cell cycle (Crosby and Almasan, 2004). It has also been
demonstrated that E2F4 may be transcriptionally repressed by
E2F1 (Ma et al., 2004). These findings suggest that the activation
of E2F1 may inhibit the function of E2F4 in mammalian SCI.
This is consistent with previous reports demonstrating that
antioxidant therapies (Bains and Hall, 2012) and inhibition of
E2F1 (Wu et al., 2012) confers neuroprotection after SCI in
mammals. It has been demonstrated that forced expression of
cyclin-dependent kinase inhibitor 1A (CDKN1A) can promote
axonal regeneration following SCI in rats (Tanaka et al., 2004).
CDKN1A inhibits E2F1 (Ookawa et al., 2001) and activates E2F4
(Benson et al., 2014). These studies suggest that CDKN1A may
be inhibited after SCI in mammals, resulting in the activation of
E2F1, and inhibition of E2F4. Activation of E2F4 may therefore
be a therapeutic strategy after SCI in mammals.
Screening Chemicals and Genes for
Treatment of SCI Using Larval Zebrafish
In this study, we developed a SCI model using larval zebrafish
that can be used to assess neuronal regeneration by in vivo
imaging and functional recovery by behavioral profiling in multi-
well-plates. Zebrafish can absorb a wide range of chemicals
from the medium in which they swim, and metabolize them
in a similar way to mammals (Nishimura et al., 2015a).
Zebrafish are also highly amenable to genome editing (Kotani
et al., 2015). Phenotype-based screening using zebrafish has
successfully discovered novel therapeutic drugs, novel uses for
existing drugs and novel disease-related genes (MacRae and
Peterson, 2015). Integration of screening using zebrafish and
detailed characterization using rodents may minimize risks in
extrapolating animal model data to human biology (Sogorb et al.,
2014). Behavioral profiling and in vivo imaging of neuronal cells
using larval zebrafish is a useful strategy for identifying genes and
chemicals promoting recovery after SCI.
In summary, we demonstrated that activation of e2f4 may be
responsible, at least in part, for significant recovery after SCI
in zebrafish. This provides novel insights into the mechanism
underlying the poor recovery after SCI in mammals, and into
potential therapeutic strategies.
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mouse SCI at 3 dpi; S2-2, DEGs in rat SCI at 3 dpi; S2-3, DEGs in zebrafish SCI
at 3 dpi; S2-4, DEGs common among mouse, rat, and zebrafish SCI at 3 dpi;
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3 dpi; S3-3, Gene ontologies enriched in DEGs specific for mouse/rat SCI at 1
dpi; S3-4, Gene ontologies enriched in DEGs specific for mouse/rat SCI at 3 dpi.
Table S4 | Transcription factors potentially regulating DEGs specific for
zebrafish SCI or mouse/rat SCI. S4-1, Transcription factors potentially
regulating DEGs specific for zebrafish SCI; S4-2, Transcription factors potentially
regulating DEGs specific for mouse/rat SCI.
Table S5 | DEGs specific for zebrafish or mouse/rat SCI potentially
regulated by TFs. S5-1 DEGs specific for zebrafish SCI at 1 dpi potentially
regulated by at least two of e2f4, tfdp1, and foxm1; S5-2, DEGs specific for
zebrafish SCI at 3 dpi potentially regulated by at least two of e2f4, tfdp1, and
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foxm1; S5-3, DEGs specific for mouse/rat SCI at 1 dpi potentially regulated by
Nfic and Tead4; S5-4, DEGs specific for mouse/rat SCI at 3 dpi potentially
regulated by Nfic and Tead4.
Table S6 | Gene ontologies enriched in DEGs potentially regulated by TFs.
S6-1 Gene ontologies enriched in DEGs specific for zebrafish SCI at 1 dpi
potentially regulated by at least two of e2f4, tfdp1, and foxm1; S6-2, Gene
ontologies enriched in DEGs specific for zebrafish SCI at 3 dpi potentially
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Movie S1 | Cutting the zebrafish spinal cord using a microdissection
device.
Movie S2 | Locomotion of zebrafish with SCI responding to the change
from light to dark conditions.
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